RESULTS	Finally , for all subjects , fasting plasma glucose and HbA1c were 200 + / - 27 mg/dL and 11.9 + / - 2.0 % , respectively , during treatment with first-generation drugs and did not change significantly following therapy with the second-generation agents ( fasting plasma glucose , 205 + / - 20 mg/dL ; HbA1c , 11.2 + / - 1.2 % ) .\